Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense

Paul J. Davis; Shaker A. Mousa; Hung Yun Lin

doi:10.4155/fmc-2018-0123

Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense

Paul J. Davis, Shaker A. Mousa, Hung Yun Lin

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Pages (from-to)	1637-1639
Number of pages	3
Journal	Future Medicinal Chemistry
Volume	10
Issue number	14
DOIs	https://doi.org/10.4155/fmc-2018-0123
Publication status	Published - Jan 1 2018

ASJC Scopus subject areas

Molecular Medicine
Pharmacology
Drug Discovery

Access to Document

10.4155/fmc-2018-0123

Cite this

@article{ebd50429a70a467995e257bf889e2aa5,

title = "Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense",

author = "Davis, {Paul J.} and Mousa, {Shaker A.} and Lin, {Hung Yun}",

year = "2018",

month = jan,

day = "1",

doi = "10.4155/fmc-2018-0123",

language = "English",

volume = "10",

pages = "1637--1639",

journal = "Future Medicinal Chemistry",

issn = "1756-8919",

publisher = "Future Science",

number = "14",

}

TY - JOUR

T1 - Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense

AU - Davis, Paul J.

AU - Mousa, Shaker A.

AU - Lin, Hung Yun

PY - 2018/1/1

Y1 - 2018/1/1

UR - http://www.scopus.com/inward/record.url?scp=85050764626&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85050764626&partnerID=8YFLogxK

U2 - 10.4155/fmc-2018-0123

DO - 10.4155/fmc-2018-0123

M3 - Editorial

AN - SCOPUS:85050764626

SN - 1756-8919

VL - 10

SP - 1637

EP - 1639

JO - Future Medicinal Chemistry

JF - Future Medicinal Chemistry

IS - 14

ER -

Tetraiodothyroacetic acid (tetrac), integrin αvβ3 and disabling of immune checkpoint defense

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this